Results 141 to 150 of about 2,469 (244)

Intent classification for university administrative services using a bidirectional recurrent neural network modified by a developed Kepler optimization algorithm. [PDF]

Sci Rep
Yang Z, Lu M, Huang S.
europepmc   +1 more source

Patch Test Results With Additions to the European Baseline Series, 2021/22—Joint European Results of the ESSCAA and the EBSB Working Groups of the ESCD, and the GEIDACC

Contact Dermatitis, EarlyView.
ABSTRACT Background Allergens are periodically added to the European Baseline Series (EBS) to audit their value in consecutive patch testing. Objectives To present results of audit allergens tested in consecutive patients in 54 departments in 13 European countries during 2021 and 2022.
Wolfgang Uter, Stephen Mark Wilkinson, Andrea Bauer, Leopoldo Borrego, Richard Brans, Timo Buhl, Heinrich Dickel, Rosella Gallo, Ana Giménez Arnau, Margarida Gonçalo, Dimitra Koumaki, Alexander A. Navarini, Cataldo Patruno, Györgyi Pónyai, Thomas Rustemeyer, Radoslaw Spiewak, Luca Stingeni, Skaidra Valiukevičienė, Marie‐L. A. Schuttelaar, Olivier Aerts, the ESSCA, EBS, ESCD working groups, the GEIDAC, Birger Kränke, Ella Dendooven, Dagmar Simon, Philip Spring, Ulrike Beiteke, Cecilia Dietrich, Sibylle Schliemann, Detlef Becker, Swen Malte John, Nicola Wagner, Elke Weisshaar, Stamatis Gregoriou, Maddalena Napolitano, Philippa Cousen, Graham A. Johnston, Juan Francisco Silvestre Salvador, José Manuel Carrascosa Carrillo, Mónica Munera Campos, Esther Serra Baldrich, Gemma Melé‐Ninot, Cristina Barrabés Torrella, David Pesqué, Ana María Giménez Arnau, María Antonia Pastor Nieto, Francisco Navarro Triviño, Leopoldo Borrego, Inmaculada Ruiz Gonzales, Enrique Gómez de la Fuente, Susana Córdoba Guijarro, Francisco Javier Ortiz de Frutos, Fátima Tous Romero, Tatiana Sanz Sánchez, Pablo Chicharro Manso, Marta Andreu Barasoain, Marta Elosua González, Araceli Sánchez Gilo, Paloma Sánchez‐Pedreño Guillén, Pedro Mercader‐García, Carmen Paredes Suárez, María Elena Gatica Ortega, José Juan Pereyra Rodríguez, Javier Miquel Miquel, Mercedes Rodríguez Serna, Violeta Zaragoza Ninet, Ricardo González Pérez   +68 more
wiley   +1 more source

Psychometric properties and local normative references of PSC-17, RCADS-25, CATS-2, SNAP-IV, MCHAT-R/F, and CAST: data from a nationwide sample in Greece. [PDF]

J Patient Rep Outcomes
Simioni A, Schafer JL, Marchionatti LE, Schuster K, Casella CB, Papanikolaou K, Kapsimalli E, Balikou P, Gerostergios G, Triantafyllou K, Basta M, Zilikis N, Athanasopoulou L, Dafoulis V, Serdari A, Bastos RVS, Szatmari P, Giannopoulou I, Koumoula A, Salum GA, Kotsis K.   +20 more
europepmc   +1 more source

Investigating the psychometric properties of a South African adaptation of the Boston Naming Test : evidence for diagnostic validity from a memory clinic population

, 2013
Includes abstract.The Boston Naming Test (BNT) is a popular confrontation naming test that is frequently used in the detection of naming deficits in Alzheimer's disease (AD). However, the test may not be appropriate when used outside of North America due
Baerecke, Lauren
core  

Parental Mental Health, Feeding Practices, and Sociodemographic Factors as Determinants of Childhood Obesity in Greece. [PDF]

Nutrients
Stymfaliadi V, Manios Y, Androutsos O, Michou M, Angelopoulou E, Tigani X, Pipelias P, Katsouli S, Kanaka-Gantenbein C.   +8 more
europepmc   +1 more source

Screening for brain‐related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener

Developmental Medicine &Child Neurology, EarlyView.
The Brain Involvement iN Dystrophinopathies (BIND) screener is an 18‐item questionnaire with strong reliability and validity for identifying potential brain‐related comorbidities in Duchenne muscular dystrophy. It allows rapid, cross‐age and cross‐country screening for both clinical and research purposes, demonstrating good sensitivity and specificity.
Ruben Miranda, Pien M. M. Weerkamp, Anna Kolesnik, Chloe Geagan, Daniela Chieffo, Mariana Suárez‐Bagnasco, David Skuse, Elizabeth Vroom, Erik H. Niks, John Vissing, Isabelle Desguerre, Volker Straub, Francesco Muntoni, Eugenio Mercuri, Jos G. M. Hendriksen, on behalf of BIND Consortium, Nathalie Angeard, Dimitrios Athanasiou, Suzie‐Ann Bakker, Nathalie Boddaert, Ellie Drummond, Chloe Durrlemann, Fernanda Fortunato, Luis Miguel García‐Moreno, Mattia Gervasi, Rosanne Govaart, Irina Guliaeva, Catherine Hankinson, Leslie Hemar, Rebecca Hendel, Hermien Kan, Leevi Kerkela, Gregory Landon, Monika Malinova, William Mandy, Federica Moriconi, Monia Pellizzari, Sarah Poncet, Elvina Sakellariou, Sergiu Siminiuc, Anna Würgler Slipsager, Lily Smythe, Pietro Spitali, Mads Peter Godtfeldt Stemmerik, Asmus Vogel, Jeanne Wolstencroft, Camilla Zanetti   +46 more
wiley   +1 more source

Pharmacist-assessed medication adherence and quality of life in patients with epilepsy. [PDF]

J Pharm Policy Pract
Petrides M, Peletidi A, Polyzois S, Nena E, Constantinidis T, Kontogiorgis C.   +5 more
europepmc   +1 more source

The cerebral palsy directed acyclic graph: A structural causal model of aetiology

Developmental Medicine &Child Neurology, EarlyView.
The first international cerebral palsy directed acyclic graph (CP‐DAG) maps over 100 nodes and 370 links across biological, clinical, and social domains, offering a unified causal framework to guide research and identify knowledge gaps. Abstract Aim To describe the development of the initial version of the cerebral palsy (CP) directed acyclic graph ...
Shona Goldsmith, Sarah McIntyre, Nadia Badawi, Bernard Dan, Steven Day, Kate Himmelmann, Sandra Julsen Hollung, Bo Jacobsson, Gija Rackauskaite, Robert J. Reynolds   +9 more
wiley   +1 more source

Workplace Gaslighting: Implications for Employees' Mental Health and Work Life in Greece. [PDF]

Healthcare (Basel)
Moisoglou I, Katsiroumpa A, Konstantakopoulou O, Mangoulia P, Tsiachri M, Koinis A, Kyriakatis GM, Galanis P.   +7 more
europepmc   +1 more source

Randomised Controlled Multicentre Trial to Investigate the Effectiveness of a Mobile Artificial Intelligence Solution for Diabetes Adapted Care: The MELISSA Trial Protocol

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Achieving optimal glycaemic control remains a burden for many people with diabetes on intensive insulin treatment. The MELISSA trial aims to clinically validate the artificial intelligence (AI)‐based MELISSA system to support people with Type 1 diabetes on multiple daily insulin injections (MDI) with personalised insulin dose ...
Elisabeth J. den Brok, Cecilie H. Svensson, Mikkel T. Olsen, Nefeli M. Dimitropoulou, Sander M. J. van Kuijk, Maria Panagiotou, Lubnaa Abdur Rahman, Stephan Proennecke, Peter R. Mertens, Stavros Athanasopoulos, Cassy F. Dingena, Konstantinos Makrilakis, Stavroula Mougiakakou, Ulrik Pedersen‐Bjergaard, Bastiaan E. de Galan, on behalf of the MELISSA consortium   +15 more
wiley   +1 more source